Compound dossier · evidence, sources, and tracked market
Bone peptide Strong evidence 0 cited studies 0 tracked vendors
A parathyroid-hormone fragment studied in research on bone-metabolism pathways.
Evidence brief
Teriparatide is a recombinant fragment of human parathyroid hormone (rhPTH 1-34) approved as an anabolic (bone-forming) osteoporosis medicine, and it has been studied in many randomized controlled trials and pooled in meta-analyses.
Published dosing & study context → Reconstitution calculator →
first-party prices captured
An approved prescription medicine for osteoporosis: FDA-approved as Forteo (NDA 021318) for postmenopausal women and men at high risk of fracture and for glucocorticoid-induced osteoporosis, centrally authorised in the EU as Forsteo, and authorised in the UK. Approved for osteoporosis only — not for any performance, recovery or anti-ageing use. Research use only — not medical advice.
Sources: Forteo (teriparatide) prescribing information · DailyMed checked 2026-08-15 · EMA · Forsteo EPAR checked 2026-08-15
Teriparatide is a recombinant fragment of human parathyroid hormone (rhPTH 1-34) approved as an anabolic (bone-forming) osteoporosis medicine, and it has been studied in many randomized controlled trials and pooled in meta-analyses.
Read the full review →Source-linked reference figures with the population and study context alongside each amount. Study arms are not a starting dose, titration schedule, or personal treatment plan. Label records refer to the named approved medicine, not vendor products.
20 mcg once daily
human · osteoporosis at high risk of fracture — postmenopausal women, men with primary or hypogonadal osteoporosis, and glucocorticoid-induced osteoporosis · FDA label (Forteo) · Route reported: subcutaneous
Read original source: Forteo (teriparatide) FDA prescribing information, DailyMed ↗20 mcg once daily
human · postmenopausal women aged 50-80 with osteoporosis · phase 3 randomised double-blind active-controlled trial · Route reported: subcutaneous
Read original source: PMID 40620511 ↗20 mcg/day or 40 mcg/day
human · postmenopausal women with osteoporosis, including mild or moderate renal impairment · randomised trial (Fracture Prevention Trial analysis) · Route reported: subcutaneous
Read original source: PMID 17013567 ↗Research use only — this reports what an FDA label or a peer-reviewed study published, tied to its species and study context. It is not medical advice, not a recommendation to use, and no dose here is generated by pepmg. Any dosing decision is for a qualified professional. Animal-study amounts do not establish a human dose.
Reconstitution calculator → · Converts your entered quantities; it does not select a dose or establish suitability for use.
Prices for this compound vary widely between vendors; comparing $/mg avoids overpaying.
Always check each vendor's third-party Certificate of Analysis (COA) for identity and purity.
| PT-141 | $2.00/mg | |
| Selank | $2.17/mg | |
| Semax | $1.35/mg | |
| DSIP | $2.20/mg | |
| Kisspeptin | $2.50/mg | |
| Thymosin Alpha-1 | $3.50/mg | |
| IGF-1 LR3 | $23.99/mg | |
| LL-37 | $4.60/mg | |
| VIP | $3.79/mg | |
| Thymalin | $2.00/mg | |
| Thymulin | $4.00/mg | |
| MGF | $10.00/mg | |
| Follistatin | $29.90/mg | |
| PNC-27 | $4.83/mg | |
| Gonadorelin | $6.55/mg | |
| HCG | —/mg | |
| Oxytocin | $3.50/mg | |
| Dihexa | $7.16/mg | |
| Adamax | $3.60/mg | |
| Cerebrolysin | $0.82/mg | |
| P-21 | $9.92/mg | |
| Methylene Blue | $1.60/mg | |
| Pinealon | $2.00/mg | |
| Cartalax | $2.00/mg | |
| Cardiogen | $1.76/mg | |
| Testagen | $2.00/mg | |
| Vilon | $2.00/mg | |
| Livagen | $2.70/mg | |
| Vesugen | $2.50/mg | |
| Prostamax | $2.60/mg | |
| Ovagen | $2.70/mg | |
| Cortagen | $2.35/mg | |
| Thymogen | $3.40/mg | |
| Chonluten | $2.55/mg | |
| Bronchogen | $2.70/mg | |
| Pancragen | $3.00/mg | |
| PE-22-28 | $3.80/mg | |
| ACE-031 | $69.99/mg | |
| FGL | $8.25/mg | |
| IGF-1 DES | $16.25/mg |
Ask how pepmg works: reading a price row, the Vendor Score, COA tiers, where prices and doses come from. Every answer links the section it comes from.
All help topics